Extended RAS Gene Mutation Testing in Metastatic Colorectal Carcinoma to Predict Response to Anti–Epidermal Growth Factor Receptor Monoclonal Antibody Therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update 2015 Summary
Author(s) -
Carmen J. Allegra,
R. Bryan Rumble,
Richard L. Schilsky
Publication year - 2016
Publication title -
journal of oncology practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.555
H-Index - 60
eISSN - 1935-469X
pISSN - 1554-7477
DOI - 10.1200/jop.2015.007898
Subject(s) - medicine , colorectal cancer , context (archaeology) , oncology , epidermal growth factor receptor , clinical trial , panitumumab , clinical oncology , cancer , exon , cetuximab , phases of clinical research , targeted therapy , gene , genetics , paleontology , biology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom